Skerlj Renato 4
4 · X4 Pharmaceuticals, Inc · Filed Jun 11, 2020
Insider Transaction Report
Form 4
Skerlj Renato
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-06-10+50,000→ 50,000 totalExercise: $8.69Exp: 2030-06-09→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on June 10, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.